Surge Therapeutics

0 followers


SURGE seeks to dramatically improve cancer patient survival by disrupting how, when, and where cancer immunotherapy is deployed -- focusing 100% of the effective dose at the right place and at the right time.

Industries

Headquarters

Employees

Links

Org chart

Michael Goldberg

Collapse
Kayti Aviano
VP, Clinical Operations
Paul Konowicz
Head of Formulations